BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 12838665)

  • 1. [Molecular epidemiologic surveillance and antifungal agent sensitivity of Candida albicans isolated from anesthesia intensive care units].
    Gülay Z; Ergon C; Ozkütük A; Yücesoy M; Biçmen M
    Mikrobiyol Bul; 2002; 36(3-4):309-16. PubMed ID: 12838665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular epidemiology of Candida species isolated from urine at an intensive care unit.
    Ergon MC; Gülay Z
    Mycoses; 2005 Mar; 48(2):126-31. PubMed ID: 15743431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular epidemiology and antifungal susceptibility of Candida species isolated from urine samples of patients in intensive care unit].
    Yüksekkaya S; Fındık D; Arslan U
    Mikrobiyol Bul; 2011 Jan; 45(1):137-49. PubMed ID: 21341168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular epidemiology of Candida species isolated from clinical specimens of intensive care unit patients.
    Marol S; Yücesoy M
    Mycoses; 2008 Jan; 51(1):40-9. PubMed ID: 18076594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
    Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
    Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species distribution, antifungal susceptibility and clonal relatedness of Candida isolates from patients in neonatal and pediatric intensive care units at a medical center in Turkey.
    Kuzucu C; Durmaz R; Otlu B; Aktas E; Gulcan H; Cizmeci Z
    New Microbiol; 2008 Jul; 31(3):401-8. PubMed ID: 18843896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of yeasts isolated from patients in intensive care units to fluconazole and amphotericin B during a 3-year period.
    Kucukates E; Erturan Z; Susever S; Yegenoglu Y
    APMIS; 2005 Apr; 113(4):278-83. PubMed ID: 15865609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
    Hüseyin A; Sancak B; Arikan S
    Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of candidemia in a Turkish tertiary care hospital.
    Bakir M; Cerikcioglu N; Barton R; Yagci A
    APMIS; 2006 Sep; 114(9):601-10. PubMed ID: 16948812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biofilm production and antifungal susceptibility patterns of Candida species].
    Yücesoy M; Karaman M
    Mikrobiyol Bul; 2004; 38(1-2):91-8. PubMed ID: 15293907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Short communication: In vitro activity of amphotericin B with fluconazole or voriconazole combinations against Candida albicans isolates].
    Oz Y; Akşit F; Kiraz N; Kiremitçi A
    Mikrobiyol Bul; 2008 Jan; 42(1):149-55. PubMed ID: 18444574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiology of candidemia: results of a one month French hospitals-based surveillance study in 2004].
    Eloy O; Blanc V; Pina P; Gaudart A; Bressolle ML; Plainvert C; Decousser JW; Pangon B; Allouch PY;
    Pathol Biol (Paris); 2006; 54(8-9):523-30. PubMed ID: 17029814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multicenter study on nosocomial candidiasis in the Republic of Argentina].
    Rodero L; Davel G; Córdoba S; Soria M; Canteros C; Hochenfellner F
    Rev Argent Microbiol; 1999; 31(3):114-9. PubMed ID: 10509389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period.
    Comert F; Kulah C; Aktas E; Eroglu O; Ozlu N
    Mycoses; 2007 Jan; 50(1):52-7. PubMed ID: 17302749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Candida albicans resistance and genotyping by randomly amplified polymorphic DNA method].
    Qian J; Zha GZ; Yu P
    Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):327-30. PubMed ID: 12205990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features.
    Kim MN; Shin JH; Sung H; Lee K; Kim EC; Ryoo N; Lee JS; Jung SI; Park KH; Kee SJ; Kim SH; Shin MG; Suh SP; Ryang DW
    Clin Infect Dis; 2009 Mar; 48(6):e57-61. PubMed ID: 19193113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Candida species in different hospital wards and their susceptibility to antifungal agents: results of a three year survey.
    Fadda ME; Podda GS; Pisano MB; Deplano M; Cosentino S
    J Prev Med Hyg; 2008 Jun; 49(2):69-74. PubMed ID: 18847180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility profile of vaginal isolates of Candida albicans prior to and following fluconazole introduction - impact of two decades.
    Bulik CC; Sobel JD; Nailor MD
    Mycoses; 2011 Jan; 54(1):34-8. PubMed ID: 19563489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of different primers used for the genotyping of Candida albicans clinical isolates by randomly amplified polymorphic DNA method].
    Saran B; Karahan ZC; Ağirbaşli H; Tekeli A; Aksoy AM
    Mikrobiyol Bul; 2008 Oct; 42(4):645-54. PubMed ID: 19149086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.